New MRD monitoring techniques could be most accurate predictor of relapse in MM patients
ASH: setting the scene for new standards of care
Results of Phase Ib/II study of ricolinostat in multiple myeloma
Debate on the use of MRD for multiple myeloma management
Bruno Paiva et al.
Effective antibody therapy and updates from the POLLUX and CASTER trials at IMW